Anesthesiol Clin. 2026 Jun;44(2):369-381. doi: 10.1016/j.anclin.2026.02.013. Epub 2026 Mar 14.
ABSTRACT
The 2024 guideline addresses perioperative cardiovascular risk in adults aged over 18 years planning noncardiac procedures, focusing on those with risk factors or conditions that increase perioperative risk. It emphasizes guideline-directed medical therapy, which includes clinical evaluation, targeted testing, and appropriate medical or interventional treatments for both short-term and long-term benefits. The guideline stresses the need for ongoing care and lifestyle modifications beyond the surgical period to reduce risk and improve long-term outcomes. Elevated risk is defined as a greater than 1% chance of major adverse cardiovascular events, but extensive preoperative testing is discouraged for low-risk procedures.
PMID:42069400 | DOI:10.1016/j.anclin.2026.02.013